Immuno-Oncology 360

  • The Roosevelt Hotel, New York, New York
  • Feb 7 - 9, 2018

Key Metrics


Why Attend

Event Overview:

The Premier Meeting Across all Stakeholders in Immuno-Oncology

Immuno-Oncology 360° is a comprehensive program providing exposure to the entire spectrum of R&D, addressing key aspects from all facets of IO including:

Discovery / Preclinical Science

Translational Science

Clinical Development

Business Aspects

Investor Relations

Emerging Technologies

Biomarkers / Diagnostics

Trends in the Field

Dr Axel Hoos, GSK and Dr James Gulley, NCI, together led the design of the 4th annual Immuno-Oncology 360° program to include 70 speakers and over 60 talks. We are delighted to announce that Dr Andrew Baum  is confirmed as the investor relations plenary keynote.

Immuno-Oncology 360° provides the most up-to-date research, data and progress to help IO stakeholders:

  • Be at the forefront of the most relevant research and developments from key leadership who are at the pulse of cancer immunotherapy
  • Foster collaboration amongst those working in all aspects of cancer immunotherapy together under one roof​
  • Receive the latest pre-clinical, translational and clinical data from academic and industry
  • Identify and gain a greater understanding of what assets are available for potential combinations  
  • Create and prioritize strategies targeted toward specific tumor types​
  • Hear from IO clinical trial leaders as they cover trial design, clinical operations, the latest outcomes and lessons learned
  • Get key investor and analyst evaluations and insights on the IO landscape, challenges and what’s next
  • Hear reports on industry trends from Endpoint News and BioCentury Innovations and a progress update on the Cancer Moonshot
  • Learn about biomarker advancements in vaccines, imaging, neoantigen approaches and more
  • Obtain coverage on a wide range of emerging technologies

Who Should Attend

The program is designed for large pharma, mid-sized biopharma, biotechs and investors seeking to accelerate clinical trials in the emerging immuno oncology space.

Exhibitor Information:

Showcase your company in front of this prestigious audience.

  • Interact with attendees at your booth during Registration, Lunch, Morning and Afternoon breaks, as well as the event reception
  • Showcase your service or technology with signs front and center
  • Opportunity to Exhibit & Sponsor are still available

Benefits of being a part of the event

  • Receive passes to attend
  • Your logo with hyperlink to your website and a company description will be on the conference website
  • Have on-site branding in the materials and brochure handed out to all attendees
  • Your logo on event signs
  • Customized marketing including a discount code for attendance to give to your clients or prospects
  • Receive the confidential attendee list
  • Handshakes with the people of your choice will be facilitated

Quick-fire & Biotechnology Showcase

Novel biotechnology companies that are developing immunotherapy assets have the opportunity to showcase their data in front of large pharma and investors who are seeking new innovative sources to contribute to their pipelines to advance the treatment of cancer. Service providers have an opportunity to showcase how they are able to collaborate and partner with BioPahrm companies. The showcase package includes branding and networking benefits as follows:

  • One all-access pass to attend the event.
  • Logo and fifty word description on the conference website (with hyperlink to your site) and in the conference brochure.
  • 25% discount to your clients or anyone you want to invite to the event through a custom code that we will track for you.
  • Logo on signage at the event.
  • Literature on a shared table

Source : Event Website

Keynote Speakers

Andrew Baum, MD


Head of Global Healthcare; Managing Director, Equity Research

Future and Past Event Dates

Event Name City State Atendance Exhibitors Date
Immuno-Oncology 360 New York City New York - - Feb 24, 2021
Immuno-Oncology 360 New York City New York Estimated
Feb 26, 2020
Immuno-Oncology 360 New York City New York Estimated
Feb 06, 2019
Immuno-Oncology 360 New York New York verified
Feb 07, 2018
3rd Annual Immuno-Oncology 360 New York New York - - Feb 01, 2017

More Allergy & Clinical Immunology Events

Event Name City State Atendance Exhibitors Date
Midwinter Conference of Immunologists Pacific Grove California Estimated
- Jan 23, 2021
Immuno-Oncology 360 New York City New York - - Feb 24, 2021
American Academy of Allergy, Asthma & Immunology 2021 Annual Meeting San Diego California Estimated
- Feb 26, 2021
26th Annual Massachusetts Adult Immunization Conference 2021 Framingham Massachusetts - - Apr 13, 2021
2021 CIS Annual Meeting - Clinical Immunology Society verified
Apr 14, 2021
>> Allergy & Clinical Immunology +
Sign Up to submit your request